期刊文献+

子宫内膜异位症的血管形成机制研究 被引量:3

下载PDF
导出
摘要 由于子宫内膜异位症患者腹腔微环境的改变,炎性细胞因子、雌激素水平升高、内膜缺氧等因素促进体内促血管形成因子占优势,造成血管过度生成,促进了异位内膜的种植、生长和侵袭,血管内皮生长因子(VEGF)是至今鉴定出来的作用最强、特异性最高的促血管形成因子。通过对血管生成和调控机制的研究,为抗血管形成治疗提供重要的理论依据,可望为子宫内膜异位症的治疗另辟新径。
作者 华馥 任慕兰
出处 《国际妇产科学杂志》 CAS 2008年第5期313-316,共4页 Journal of International Obstetrics and Gynecology
  • 相关文献

参考文献20

  • 1[1]Wu MH,Shoji Y,Chuang PC,et al.Endometriosis:disease pathophysiology and the role of prostaglandins[J].Expert Rev Mol Med,2007,9(2):1-20.
  • 2[2]Hur SE,Lee JY,Moon HS,et al.Angiopoietin-1,angiopoietin-2 and Tie-2 expression in eutopic endometrium in advanced endometriosis[J].Mol Hum Reprod,2006,12(7):421-426.
  • 3[3]Laschke MW,Menger MD.In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis[J].Hum Reprod Update,2007,11 (5):67-74.
  • 4[4]Becker CM,Rohwer N,Funakoshi T,et al.2-methoxyestradiol inhibits hypoxia-inducible factor-1 {alpha} and suppresses growth of lesions in a mouse model of endometriosis[J].Am J Pathol,2008,172(2):534-544.
  • 5[5]Absenger Y,Hess-Stumpp H,Kreft B,et al.Cyr61,a deregulated gene in endometriesis[J].Mol Hum Beprod,2006,10 (6):399-407.
  • 6[6]Ferrero S,Gillott DJ,Anserini P,et al.Methodological concerns regarding levels of vascular endothelial growth factor(VEGF) in serum of patients with endometriosis[J].Hum Repred,2008,19(1):220-231.
  • 7[7]Hayrabedyan S,Kyurkchiev S,Kehayev I.FGF-1 and S100A13 possibly contribute to angiogenesis in endometriosis[J].J Reprod Immunol,2005,67(1-2):87-101.
  • 8[8]Lin YJ,Lai MD,Lei HY,et al.Neutrophils and macrophages promote angiogenesis in the early stage of endometriosis in a mouse model[J].Endocrinology,2006,147 (3):1278-1286.
  • 9[9]Hayrabedyan S,Kyurkchiev S,Kehayov I.Endoglin (cd105)and S100A13 as markers of active angiogenesis in endometriosis[J].Reprod Biol,2005,5(1):51-67.
  • 10[10]Bajou K,Maillard C,Jest M,et al.Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth[J].Oncogene,2008,23(41):6986-6990.

同被引文献31

  • 1高红军,代解杰,王红星,林海燕,王红梅.血管新生调节因子VEGF及其受体在恒河猴正常妊娠和药物流产胎盘中的表达[J].中国计划生育学杂志,2005,13(6):356-359. 被引量:11
  • 2李兆艾,智明春,乔翠峰,孙静汾.人参皂苷Rg3对大鼠子宫内膜异位症组织中血管内皮生成因子影响的研究[J].中华妇幼临床医学杂志(电子版),2006,2(2):78-80. 被引量:7
  • 3Ferrara N. History of discovery : vascular endothelial growth factor [ J ]. Arterioscler Thromb Vasc Biol, 2009,29 ( 1 ) :22 - 24.
  • 4Cook KM, Figg WD. Angiogenesis inhibitors: Current strategies and future prospects[J]. CA Cancer J Clin, 2010, 60(4) :222 -243.
  • 5Bhat TA, Singh RP. Tumor angiogenesis - A potential target in cancer chemoprevention[ J ]. Food Chem Toxicol, 2008,46 ( 4 ) : 1334 - 1345.
  • 6Otrock ZK, Makarem JA, Shamseddine AI. Vascular endothelial growth factor family of ligands and receptors: review [ J ]. Blood Ceils Mol Dis, 2007,38(3) :258 -268.
  • 7Jones MC, Caswell PT, Moran -Jones K, et al. VEGFR1 (Fltl)regulates rab4 recycling to control fibronectin polymerization and endothelial vessel branching [ J ]. Traffic, 2009, l0 (6) :754 - 766.
  • 8Cao Y. Positive and negative modulation of angiogenesis by VEGFR1 ligands[J]. Sci Signal, 2009,2(59) :rel.
  • 9Ferrara N. Vascular endothelial growth factor [ J ]. Arterioscler Thromb Vasc Biol, 2009,29(6) :789 -791.
  • 10Foidart JM, Schaaps JP, Chantraine F, et al. Dysregulation of anti - angiogenic agents (sFlt - 1, PIGF, and sEndoglin ) in preeclampsia - a step forward but not the definitive answer[ J]. J Reprod Immunol, 2009,82 ( 2 ) : 106 - 111.

引证文献3

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部